News Study of Penn Patients with Decade-Long Leukemia Remissions after CAR T Cell Therapy Reveals New Details About Persistence of Personalized “Living Drug” Cells
Video Penn Precision Medicine – Accelerator Fund Projects: Artificial-Intelligence-Driven Targeted Therapy in Acute Myeloid Leukemia